Treatment with biosimilar insulin glargine in clinical practice: case report

Česká verzia

Authors: Adriana Philippiová
Authors place of work: DIADA, s. r. o, Bardejov
Published in the journal: Diab Obez 2020; 20(39): 65
Category: Case studies

Štítky

Diabetology Obesitology

Článek Editorial

Článek Comparison of the most recent guidelines for hyperglycemia management in patients with type 2 diabetes mellitus

Článek Concentrations of fT3 in child patients with obesity

Článek Non-alcoholic fatty liver disease from the point of view of diabetologist

Článek Diabetes mellitus and liver diseases

Článek The benefit of insulin glargine 300 U/ml for specific groups of patients in the context of available data

Článek Management of antidiabetic treatment in an elderly fragile patient with diabetes mellitus

Článek Peroral antidiabetics and thyroid diseases

Článek COVID-19: the topic of the day

Článek Comparison of cardiovascular studies with GLP-1 receptor agonists and their implication for clinical practice

Článek Therapy with SGLT2 inhibitors: case reports

Článek Treatment with the new modified insulin glargine (Semglee) in a patient with type 1 diabetes mellitus: case report

Článek A positive effect of intensification of the treatment with biosimilar insulin glargine on metabolic compensation: case report

Článek Edukácia v diabetologickom edukačnom centre v Martine

Článek Diabetology EDUCATION FORUM

Článok vyšiel v časopise

Diabetes and obesity

2020 Číslo 39

Stáhnout celé číslo v PDF

Najčítanejšie tento týždeň

The Importance of Hydration in Wound Healing

Najčítanejšie v tomto čísle